Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Batulicin Nusantara Maritim Tbk (BESS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Batulicin Nusantara Maritim TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Batulicin Nusantara Maritim Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Batulicin Nusantara Maritim Tbk trades at Rp930 (market cap 3.22T, 11.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Batulicin Nusantara Maritim Tbk is far larger — about 19.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (214.9K versus 11.6K). Which is the better fit depends on your goals.

BESSOBAT
Market Cap
3.22T164.65B
Volume
11.6K214.9K
Lot
1162.15K
Turnover
10.49M51.97M
Average Price
904.18241.85
Value
10.49M51.97M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BESS
View details
OBAT
View details

About Batulicin Nusantara Maritim Tbk

PT Batulicin Nusantara Maritim Tbk (the “Company”) was established based on Notarial Deed No. 53 dated May 25, 2011 of Muhammad Faried Zain, S.H., M.H., notary in Banjarmasin. The Company’s immediate Parent Company is PT Batulicin Enam Sembilan Transportasi, and its Ultimate Parent Company is PT Batulicin Enam Sembilan. The Company started its commercial operations in 2012.

Read more on BESS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT